Single domain antibody (sdAb): Cancer research application
27 May 2020

Single domain antibody also known as VHH or nanobodies, have unique properties of size, stability and solubility which lends itself to an array of versitle applications and ability to effectively target cancer cells. Using single domain antibodies enable scientist and engineers to advance cancer research, drug-development and therapy.